DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hycotuss (Hydrocodone Bitartrate / Guaifenesin) - Summary



HYCOTUSS Expectorant Syrup contains hydrocodone (dihydrocodeinone) bitartrate, a semi-synthetic centrally-acting opioid antitussive and guaifenesin, an expectorant for oral administration.

HYCOTUSS (hydrocodone bitartrate and guaifenesin) Expectorant Syrup is indicated for the symptomatic relief of irritating non-productive cough associated with upper and lower respiratory tract congestion.

See all Hycotuss indications & dosage >>


Media Articles Related to Hycotuss (Hydrocodone / Guaifenesin)

Smoker's cough: Symptoms, causes, and home remedies
Source: Lung Cancer News From Medical News Today [2017.08.14]
In this article learn how many smokers have smoker's cough. What are the symptoms and causes of smokers cough and how can it be treated?

Chronic Cough
Source: MedicineNet Chronic Rhinitis Specialty [2017.05.01]
Title: Chronic Cough
Category: Symptoms and Signs
Created: 10/13/2003 12:00:00 AM
Last Editorial Review: 5/1/2017 12:00:00 AM

Vaccinating Pregnant Moms Protects Babies From Whooping Cough
Source: MedicineNet Pertussis Specialty [2017.04.03]
Title: Vaccinating Pregnant Moms Protects Babies From Whooping Cough
Category: Health News
Created: 4/3/2017 12:00:00 AM
Last Editorial Review: 4/3/2017 12:00:00 AM

Whooping Cough Symptoms
Source: MedicineNet Immunizations Specialty [2017.02.16]
Title: Whooping Cough Symptoms
Category: Doctor's & Expert's views on Symptoms
Created: 2/20/2013 12:00:00 AM
Last Editorial Review: 2/16/2017 12:00:00 AM

OTC Cold and Cough Medications
Source: MedicineNet Allergy Treatment Begins At Home Specialty [2017.01.18]
Title: OTC Cold and Cough Medications
Category: Doctor's & Expert's views on Symptoms
Created: 2/8/2005 12:00:00 AM
Last Editorial Review: 1/18/2017 12:00:00 AM

more news >>

Clinical Trials Related to Hycotuss (Hydrocodone / Guaifenesin)

Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX [Recruiting]
RATIONALE: Collecting and storing samples of tumor tissue from patients with soft tissue sarcoma to test in the laboratory may help the study of cancer in the future. PURPOSE: This laboratory is collecting tissue samples from patients with soft tissue sarcoma of the arms, hands, legs, or feet treated on clinical trial CRUK-VORTEX.

Functional Evaluation of Two Types of Totally Implanted Venous Ports [Completed]
Totally implanted venous access ports allow a safe delivery of medication, mainly chemotherapy, but are also used for blood sampling. This last procedure is not always successful, as it appeared from a nurse's survey in different hospitals in Flanders, including the University Hospitals in Leuven, Belgium. In 3 to 29 percent of the attempts, blood withdrawal is impaired or not possible, as an intermittent or permanent fact. This is in line with international literature data where difficulty in blood draw was noted in 6 to 26% of port accessions. Partial or total occlusion leads to discomfort for the patient, delay in therapy, higher costs and extra nursing time. A new port system with a tangential outlet (Vortex port) was designed and according to the manufacturer, this shape will allow to cleanse the entire reservoir of the port more efficiently and avoid the formation of precipitates of medication or blood that could lead to an obstruction of the device. These precipitates are also regarded as a potential risk factor for infection. However, only one previously published small randomised study addressed the value of the Vortex port when compared to conventional access devices: Stevens et al. were able to show a reduction in obstruction incidence from 26% to 7% with the use of the Vortex port. The incidence of blood withdrawal problems in our experience with conventional ports in University hospitals Leuven was 8% thus lower than that reported by Stevens, but this remains the most frequent problem faced by care providers and patients. With this study, the investigators aim to compare the performance of the tangential outlet ports and that of a "conventional" port in order to assess an eventual functional difference.

Implication of Left veNtricle Vortex Flow Guided aNticOagulation Therapy for preVenting Apical Thrombus Formation In Patients With Acute myOcardial infarctioN: Multicenter Prospective Randomized Clinical Trial; INNOVATION Study [Recruiting]
Implication of left veNtricle vortex flow guided aNticOagulation therapy for preVenting Apical Thrombus formation In patients with acute myOcardial infarctioN: Multicenter Prospective Randomized Clinical Trial; INNOVATION study

Impact of Enzyme Replacement Therapy on Cardiac Function in Patients With Fabry's Cardiomyopathy (RECAFTURE Trial) [Recruiting]
The purpose of this study is to evaluate the impact of ERT on LV diastolic function and flow in patients with Fabry's cardiomyopathy using diastolic stress echocardiography, LV vortex flow and CMR.

Fine Particle pMDI Formoterol/Beclomethasone in Asthmatics With and Without Spacer: Comparative Efficacy Evaluation [Completed]
Adequate pharmacological treatment controls symptoms in most asthmatics. Pressurized metered dose inhalers (pMDI)are the most used drug delivery devices. Valved holding chambers of different types and sizes have also been developed for use in combination with pMDI. The therapeutic efficacy of treatment depends on the amount of inhaled particles. The chambers can optimize lung deposition as it obviates lung-hand coordination and retain larger particles. The aim of this study is to compare the efficacy of the fine particle combination pMDI Beclomethasone/Formoterol in asthma control,with or without the aid of a spacer in patients without adequate asthma control on medium to high-dose inhaled steroids associated with long acting beta adrenergic drugs. The hypothesis is that there is no clinical efficacy difference between the two forms of drug administration.

more trials >>

Page last updated: 2017-08-14

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017